Ms. Hassan (for herself and Mr. Hawley) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions
To require sponsors of drug applications and holders of approved applications to provide certain submissions and communications to the Food and Drug Administration and the United States Patent and Trademark Office.
Citations are generated automatically from bibliographic data
as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. Senate. Medication Affordability and Patent Integrity Act. S. 2658. 119th
Cong., 1st
sess., Introduced in Senate August 1, 2025. https://www.govinfo.gov/app/details/BILLS-119s2658is.
APA
Congress, Senate (2025, August 1). Medication Affordability and Patent Integrity Act (S. 2658 (IS)). Retrieved from https://www.govinfo.gov/app/details/BILLS-119s2658is.
MLA
United States, Congress, Senate. Medication Affordability and Patent Integrity Act. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-119s2658is. 119th Congress, S. 2658, Introduced in Senate 1 Aug. 2025.
Bluebook
S.2658 - 119th Congress (2025-2026): Medication Affordability and Patent Integrity Act, S.2658, 119th Cong. (2025), https://www.govinfo.gov/app/details/BILLS-119s2658is.
